Assuming the Ph1 results support the fda application it’s very important to progress this so it is in play while the are doing the road show, round of BP.
- Forums
- ASX - By Stock
- NUZ
- FDA Application for Orphan Drug Designation , PAA, MPL
NUZ
neurizon therapeutics limited
Add to My Watchlist
2.94%
!
16.5¢

FDA Application for Orphan Drug Designation , PAA, MPL, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.5¢ |
Change
-0.005(2.94%) |
Mkt cap ! $81.23M |
Open | High | Low | Value | Volume |
16.5¢ | 17.0¢ | 16.5¢ | $36.83K | 223.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 208074 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.165 |
6 | 88626 | 0.160 |
7 | 169977 | 0.155 |
8 | 128707 | 0.150 |
2 | 303482 | 0.145 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 208074 | 7 |
0.175 | 11139 | 2 |
0.180 | 522500 | 6 |
0.185 | 109375 | 3 |
0.190 | 24925 | 2 |
Last trade - 11.33am 15/07/2025 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online